Waycross Partners’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.75M | Hold |
20,000
| – | – | 0.16% | 49 |
|
|
2025
Q1 | $1.37M | Hold |
20,000
| – | – | 0.15% | 47 |
|
|
2024
Q4 | $1.56M | Hold |
20,000
| – | – | 0.2% | 46 |
|
|
2024
Q3 | $1.34M | Hold |
20,000
| – | – | 0.19% | 48 |
|
|
2024
Q2 | $2.27M | Hold |
20,000
| – | – | 0.35% | 42 |
|
|
2024
Q1 | $2.77M | Hold |
20,000
| – | – | 0.48% | 36 |
|
|
2023
Q4 | $2.48M | Sell |
20,000
-7,850
| -28% | -$974K | 0.47% | 40 |
|
|
2023
Q3 | $2.6M | Hold |
27,850
| – | – | 0.57% | 35 |
|
|
2023
Q2 | $3.58M | Buy |
27,850
+7,450
| +37% | +$957K | 0.78% | 33 |
|
|
2023
Q1 | $2.37M | Buy |
20,400
+5,000
| +32% | +$581K | 0.69% | 39 |
|
|
2022
Q4 | $1.74M | Hold |
15,400
| – | – | 0.63% | 40 |
|
|
2022
Q3 | $1.24M | Buy |
15,400
+11,000
| +250% | +$886K | 0.83% | 41 |
|
|
2022
Q2 | $328K | Hold |
4,400
| – | – | 0.22% | 75 |
|
|
2022
Q1 | $563K | Hold |
4,400
| – | – | 0.33% | 68 |
|
|
2021
Q4 | $591K | Hold |
4,400
| – | – | 0.34% | 70 |
|
|
2021
Q3 | $602K | Hold |
4,400
| – | – | 0.38% | 66 |
|
|
2021
Q2 | $470K | Hold |
4,400
| – | – | 0.25% | 69 |
|
|
2021
Q1 | $395K | Buy |
+4,400
| New | +$395K | 0.22% | 77 |
|